Production (Stage)
NextCure, Inc.
NXTC
$6.17
$0.9117.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.08M | 15.72M | 16.13M | 17.01M | 18.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.07M | 57.21M | 60.54M | 63.66M | 66.33M |
| Operating Income | -53.07M | -57.21M | -60.54M | -63.66M | -66.33M |
| Income Before Tax | -49.52M | -55.65M | -58.52M | -61.28M | -63.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.52 | -55.65 | -58.52 | -61.28 | -63.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.52M | -55.65M | -58.52M | -61.28M | -63.73M |
| EBIT | -53.07M | -57.21M | -60.54M | -63.66M | -66.33M |
| EBITDA | -50.34M | -54.34M | -57.53M | -60.40M | -62.81M |
| EPS Basic | -21.23 | -23.89 | -25.14 | -26.35 | -27.44 |
| Normalized Basic EPS | -13.27 | -14.25 | -15.03 | -15.79 | -16.47 |
| EPS Diluted | -21.23 | -23.89 | -25.14 | -26.35 | -27.44 |
| Normalized Diluted EPS | -13.27 | -14.25 | -15.03 | -15.79 | -16.47 |
| Average Basic Shares Outstanding | 9.33M | 9.32M | 9.31M | 9.30M | 9.29M |
| Average Diluted Shares Outstanding | 9.33M | 9.32M | 9.31M | 9.30M | 9.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |